Bausch Health Companies | Umlaufvermögen



Current Assets Veränderung Datum
Amgen USD 26.93B 2.1B 2025-03
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bausch Health Companies USD 5.73B 42M 2025-03
Biogen USD 7.63B 169.2M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 438.5M 33.1M 2025-03
Danaher USD 9.52B 28M 2025-03
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Novo Nordisk 174.4B 20.76B 2025-03
Pacira USD 759.96M 14.83M 2025-03
Perrigo USD 2.53B 51.1M 2025-03
Prestige Brands USD 448.33M 71.16M 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Zoetis USD 5.88B 109M 2025-03



Bausch Health Companies Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.